News & Alerts
-
Aug- 2023 -18 August
FDA Issues Warning to AstraZeneca for Misleading COPD Drug Advertising
The absence of any drug that demonstrates a significant improvement in all-cause mortality among patients with chronic obstructive pulmonary disease…
Read More » -
18 August
Tornado Fallout: 50% of Pfizer Hospital Injectables in Short Supply
As of August 16, 2023, approximately half of the injectable drug solutions produced by Pfizer Hospital US are experiencing significant…
Read More » -
18 August
Breaking Ground: FDA Approves Akeega for Aggressive Prostate Cancer Treatment
The U.S. Food & Drug Administration’s approval of Akeega marks a significant advancement in the treatment landscape for individuals with…
Read More » -
18 August
Why Eligible Infants and Children Should Get The New RSV Medication – AAP
Respiratory Syncytial Virus (RSV) is a widespread viral infection that predominantly targets the respiratory system, particularly the lungs and airways.…
Read More » -
17 August
10 Free Online Courses for Drug Safety Specialists
The field of drug safety is of paramount importance in the pharmaceutical industry, ensuring that medicines are safe and effective…
Read More » -
17 August
Ipsen’s Sohonos (palovarotene) Capsules Approved by FDA for Managing Debilitating Bone Disorder
In a landmark development, Ipsen has officially received approval from the U.S. Food and Drug Administration (FDA) for its groundbreaking…
Read More » -
17 August
Ozempic’s Financial Triumphs and the CMS Negotiation Horizon
Ozempic, a prominent Type 2 diabetes drug, appears to be at the cusp of potential involvement with the Centers for…
Read More » -
16 August
UK NHS Joins Forces with IAOCR to Launch Clinical Trials Talent Taskforce
In a pivotal stride towards revitalizing the landscape of clinical research, the United Kingdom’s National Health Service (NHS) has forged…
Read More » -
16 August
GSK and Innoviva Forge Ahead to Combat Drug-Resistant Gonorrhea
The growing incidence of drug-resistant gonorrhea has raised alarm bells within the medical community, prompting both concern and urgency. In…
Read More » -
16 August
FDA Imposes Clinical Hold on Leukemia Drug Trial Following Participant’s Death
Following the unfortunate incident involving a participant’s death, a Massachusetts-based pharmaceutical company found itself facing a significant setback in its…
Read More »